title: Should individuals with anti-HBs as the only marker of infection with hepatitis B receive hepatitis B vaccine?
authors.forename: J E
authors.initials: JE
authors.lastname: MacLeod
authors.forename: H M
authors.initials: HM
authors.lastname: MacSween
authors.forename: H A
authors.initials: HA
authors.lastname: Warner
authors.forename: K
authors.initials: K
authors.lastname: Aterman
mesh_terms: D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D017325:Hepatitis B Vaccines; D006801:Humans; D007114:Immunization; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000517:prevention & control*; D010564:Personnel, Hospital; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage*
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines